Flecainide Acetate combined with Warfarin Sodium

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Renal Failure Acute Hospitalization 11/16/2005 Male 2/15/2006 Pharmacist United States
Primary
Concomitant
Pharmaceutical Product Complaint Hospitalization 2/21/2006 80 Female 142 lb 5/9/2006 Consumer United States
Primary
Concomitant
Periorbital Oedema Hospitalization 4/4/2006 84 Female 5/24/2006 Other Health Professional France
Primary
Concomitant
Interacting
Ventricular Hypertrophy Hospitalization 2/21/2006 80 Female 142 lb 5/26/2006 Physician United States
Primary
Concomitant
Periorbital Oedema Other Serious 4/4/2006 84 Female 7/6/2006 Other Health Professional France
Primary
Concomitant
Interacting
Hypoalbuminaemia Required Intervention 1/17/2006 40 Female 106 lb 9/20/2006 Physician Japan
Primary
Concomitant
Pyrexia Other Serious 1/1/2006 81 Female 9/26/2006 Consumer United States
Primary
Concomitant
Urinary Incontinence Other Serious 4/4/2006 84 Female 134 lb 10/20/2006 Other Health Professional France
Primary
Concomitant
Interacting
Treatment Noncompliance Hospitalization 7/8/2006 82 Male 218 lb 8/9/2006 Pharmacist United States
Primary
Secondary
Concomitant
International Normalised Ratio Increased Life Threatening 70 Male 12/14/2006 United Kingdom
Primary
Secondary
Concomitant
Conduction Disorder Hospitalization 11/29/2006 79 Male 1/16/2007 Italy
Primary
Secondary
Concomitant
Skin Exfoliation 12/25/2006 79 Male 1/31/2007 United Kingdom
Primary
Concomitant
Weight Decreased Other Serious 11/3/2006 Male 215 lb 3/8/2007 Consumer United States
Primary
Concomitant
Sweat Discolouration 64 Male 3/27/2007 Physician United States
Primary
Concomitant
Hyperhidrosis 62 Male 185 lb 3/27/2007 Physician United States
Primary
Concomitant
Gait Disturbance 8/1/2005 52 Female 369 lb 1/23/2007 Pharmacist United States
Primary
Concomitant
Weight Decreased Other Serious 11/3/2006 Male 215 lb 4/30/2007 Consumer United States
Primary
Concomitant
Pain In Extremity 8/22/2006 85 Female 160 lb 2/6/2007 Physician United States
Primary
Concomitant
Sleep Walking Other Serious 75 Male 3/12/2007 Consumer United States
Primary
Concomitant
Tremor Other Serious 1/1/2006 80 Female 123 lb 6/25/2007 United States
Primary
Concomitant
Vaginal Infection Other Serious 1/1/2006 80 Female 123 lb 7/26/2007 United States
Primary
Concomitant
Vaginal Infection Other Serious 1/1/2006 80 Female 123 lb 7/27/2007 United States
Primary
Concomitant
Heart Rate Increased Other Serious 10/13/2007 Other Health Professional United States
Primary
Secondary
Concomitant
Nausea Other Serious 10/1/2007 75 Male 11/13/2007 Consumer United States
Primary
Concomitant
Nasopharyngitis 11/23/2007 Male 12/3/2007 Consumer United States
Primary
Concomitant
Visual Acuity Reduced Other Serious 6/1/2007 78 Female 11/29/2007 Consumer United States
Primary
Secondary
Concomitant
Nasopharyngitis 11/23/2007 Male 12/5/2007 Consumer United States
Primary
Concomitant
Pulmonary Congestion 11/8/2007 Male 1/2/2008 Pharmacist United States
Primary
Concomitant
Somnambulism Other Serious 75 Male 160 lb 12/4/2007 Consumer United States
Primary
Concomitant
Pulmonary Congestion 11/8/2007 Male 2/5/2008 Pharmacist United States
Primary
Concomitant
Nasopharyngitis 11/23/2007 Male 2/12/2008 Consumer United States
Primary
Concomitant
Withdrawal Syndrome Other Serious 1/20/2008 62 Female 2/14/2008 United States
Primary
Concomitant
Syncope Life Threatening 2/20/2008 Female 3/24/2008 Pharmacist United States
Primary
Concomitant
Convulsion Other Serious 1/5/2007 Male 209 lb 4/15/2008 Consumer United States
Primary
Concomitant
Vulvovaginal Dryness Disability 64 Female 4/10/2008 Physician United Kingdom
Primary
Concomitant
Abasia Other Serious 4/29/2008 Female 137 lb 5/9/2008 United States
Primary
Concomitant
Stomach Discomfort 2/11/2008 67 Female 270 lb 5/1/2008 Consumer United States
Primary
Concomitant
Overdose Death 4/1/2008 50 Male 231 lb 6/4/2008 Other Health Professional Canada
Primary
Secondary
Concomitant
Pain In Extremity Hospitalization 4/1/2008 57 Male 6/6/2008 Other Health Professional Norway
Primary
Concomitant
Weight Increased Other Serious Female 6/11/2008 Consumer United States
Primary
Concomitant
Myalgia Other Serious 78 Male 219 lb 6/20/2008 United States
Primary
Concomitant
International Normalised Ratio Fluctuation 3/19/2007 Male 205 lb 7/29/2008 Consumer United States
Primary
Concomitant
Alopecia 75 Female 7/29/2008 Consumer United States
Primary
Secondary
Concomitant
Vision Blurred Hospitalization 1/1/2008 Female 157 lb 8/5/2008 Consumer United States
Primary
Secondary
Concomitant
Xanthopsia Other Serious 79 Female 8/11/2008 United States
Primary
Concomitant
Vision Blurred Hospitalization 1/1/2008 Female 157 lb 8/22/2008 Physician United States
Primary
Secondary
Concomitant
Vision Blurred Other Serious Female 157 lb 8/22/2008 Physician United States
Primary
Secondary
Concomitant
Xanthopsia Other Serious 4/26/2008 79 Female 8/20/2008 United States
Primary
Concomitant
Nervousness 69 Female 190 lb 10/15/2008 United States
Primary
Concomitant
Tinnitus Disability 9/20/2008 Female 10/29/2008 Pharmacist United States
Primary
Concomitant
Tinnitus Disability 9/20/2008 Female 11/24/2008 Pharmacist United States
Primary
Concomitant
Medication Residue 1/1/2005 Male 240 lb 12/4/2008 Physician United States
Primary
Concomitant
International Normalised Ratio Increased Life Threatening 2/8/2009 70 Female 2/26/2009 United Kingdom
Primary
Secondary
Concomitant
International Normalised Ratio Increased Life Threatening 2/8/2009 70 Female 3/9/2009 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
International Normalised Ratio Increased Life Threatening 2/8/2009 70 Female 3/5/2009 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
International Normalised Ratio Increased Life Threatening 2/8/2009 70 Female 3/6/2009 United Kingdom
Primary
Secondary
Concomitant
Tinnitus Disability 9/20/2008 Female 3/18/2009 Pharmacist United States
Primary
Concomitant
Skin Discolouration Other Serious 2/28/2009 Male 206 lb 3/25/2009 Other Health Professional United States
Primary
Concomitant
International Normalised Ratio Increased Life Threatening 2/8/2009 70 Female 3/26/2009 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
International Normalised Ratio Increased Life Threatening 2/8/2009 70 Female 3/26/2009 Consumer United Kingdom
Primary
Secondary
Concomitant
Therapeutic Reaction Time Decreased 1/1/2009 Female 4/14/2009 Consumer
Primary
Concomitant
Skin Discolouration Other Serious 2/28/2009 Male 206 lb 4/17/2009 Other Health Professional United States
Primary
Concomitant
Kidney Infection Other Serious 65 Female 176 lb 5/21/2009 Consumer United States
Primary
Concomitant
Vision Blurred Hospitalization 87 Male 5/28/2009 Other Health Professional United States
Primary
Concomitant
Vision Blurred Hospitalization 87 Male 6/4/2009 Other Health Professional United States
Primary
Concomitant
Wheezing Hospitalization 6/12/2009 72 Male 6/25/2009 Other Health Professional France
Primary
Concomitant
Social Avoidant Behaviour Hospitalization 69 Female 138 lb 6/23/2009 Pharmacist United States
Primary
Concomitant
Tinnitus Hospitalization 6/14/2009 85 Female 114 lb 7/8/2009 Pharmacist United States
Primary
Secondary
Concomitant
Skin Wrinkling 72 Female 7/22/2009 Consumer United States
Primary
Secondary
Concomitant
Skin Wrinkling 72 Female 7/22/2009 Consumer United States
Primary
Secondary
Concomitant
Nausea Hospitalization 64 Female 8/20/2009 Lawyer United States
Primary
Concomitant
International Normalised Ratio Increased Life Threatening 70 Male 9/15/2009 Other Health Professional United Kingdom
Primary
Concomitant
Screaming Hospitalization 69 Female 138 lb 9/15/2009 United States
Primary
Secondary
Concomitant
Thrombosis Required Intervention 6/8/2009 66 Female 190 lb 9/18/2009 Other Health Professional United States
Primary
Concomitant
Social Avoidant Behaviour Other Serious 69 Female 138 lb 9/25/2009 Pharmacist United States
Primary
Secondary
Concomitant
Drug Toxicity Hospitalization 69 Female 139 lb 10/2/2009
Primary
Secondary
Stress Hospitalization 61 Female 180 lb 9/28/2009 United States
Primary
Concomitant
Heart Rate Irregular Other Serious 1/1/2004 81 Male 11/6/2009 Consumer United States
Primary
Secondary
Concomitant
Skin Exfoliation Other Serious 12/25/2006 79 Male 168 lb 11/23/2009 Other Health Professional United Kingdom
Primary
Concomitant
Thrombocytopenia Hospitalization 12/8/2000 70 Male 260 lb 11/16/2009 United States
Primary
Concomitant
Unevaluable Event Hospitalization 66 Male 11/16/2009 Lawyer United States
Primary
Concomitant
Thrombocytopenia Hospitalization 12/8/2000 70 Male 260 lb 11/24/2009 United States
Primary
Concomitant
Skin Exfoliation Other Serious 12/25/2006 79 Male 12/2/2009 Other Health Professional United Kingdom
Primary
Concomitant
Skin Exfoliation Other Serious 12/25/2006 79 Male 168 lb 11/30/2009 United Kingdom
Primary
Concomitant
Skin Exfoliation Other Serious 12/25/2006 79 Male 168 lb 11/30/2009
Primary
Concomitant
Unevaluable Event Hospitalization 66 Male 12/2/2009 Lawyer United States
Primary
Concomitant
Thrombocytopenia Hospitalization 12/8/2000 70 Male 260 lb 1/22/2010 United States
Primary
Concomitant
Pulmonary Oedema Hospitalization 12/17/2009 81 Male 203 lb 2/9/2010 Pharmacist United States
Primary
Concomitant
Sensation Of Foreign Body 4/29/2009 67 Female 2/17/2010 Other Health Professional United States
Primary
Concomitant
Urinary Incontinence Other Serious 3/16/2010 73 Male 4/5/2010 Japan
Primary
Concomitant
Urinary Incontinence Other Serious 3/16/2010 73 Male 4/20/2010 Japan
Primary
Concomitant
Urticaria Other Serious 4/7/2010 42 Female 137 lb 4/29/2010 Other Health Professional United Kingdom
Primary
Concomitant
International Normalised Ratio Increased Life Threatening 2/8/2009 70 Female 5/7/2010 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Urinary Incontinence Other Serious 3/16/2010 73 Male 5/12/2010 Japan
Primary
Concomitant
International Normalised Ratio Increased Life Threatening 2/8/2009 70 Female 6/2/2010 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Drug Ineffective 1/1/2007 79 Male 148 lb 7/31/2010 Other Health Professional United States
Primary
Concomitant
Injection Site Urticaria 12/18/2009 68 Male 4/15/2010 United States
Primary
Concomitant
Injection Site Urticaria 12/18/2009 68 Male 1/26/2010 United States
Primary
Concomitant
Ventricular Hypertrophy Other Serious 12/8/2000 72 Male 260 lb 8/10/2010 United States
Primary
Concomitant
Off Label Use Disability 9/1/2009 73 Female 143 lb 8/12/2010 United Kingdom
Primary
Concomitant
Skin Burning Sensation Male 215 lb 8/28/2010 United States
Primary
Concomitant
Wheezing Other Serious 7/6/2010 69 Female 185 lb 9/17/2010 Other Health Professional United States
Primary
Concomitant
Urinary Tract Infection Hospitalization 9/10/2010 70 Female 9/30/2010 Physician United States
Primary
Secondary
Concomitant
Cerebral Ischaemia Hospitalization 1/1/2007 68 Male 3/3/2011 Physician United States
Primary
Concomitant
Anticonvulsant Drug Level Above Therapeutic Hospitalization 64 Female 4/25/2011 United States
Primary
Concomitant
Abdominal Pain Upper 2/1/2011 Female 6/7/2011 Consumer United States
Primary
Concomitant
Arrhythmia Hospitalization 3/13/2011 72 Female 6/10/2011 Consumer United States
Primary
Concomitant
Pneumonia Hospitalization 11/1/2010 75 Female 146 lb 6/14/2011 Physician Australia
Primary
Concomitant
Somnolence 2/1/2010 74 Male 215 lb 6/16/2011 Consumer United States
Primary
Secondary
Concomitant
Contusion 81 Female 6/21/2011 Consumer United States
Primary
Concomitant
Eructation 4/1/2011 65 Female 6/27/2011 Consumer United States
Primary
Concomitant
Loss Of Consciousness Hospitalization 5/24/2011 83 Male 7/1/2011 Physician Italy
Primary
Concomitant
Loss Of Consciousness Hospitalization 5/23/2011 83 Male 148 lb 7/19/2011 Consumer Italy
Primary
Concomitant
Pain Other Serious 62 Female 7/25/2011 Consumer United States
Primary
Secondary
Concomitant
Alopecia 1/1/2010 69 Female 7/25/2011 Consumer United States
Primary
Concomitant
Deep Vein Thrombosis Other Serious 50 Female 7/29/2011 Other Health Professional Australia
Primary
Secondary
Atrial Fibrillation Hospitalization 64 Male 201 lb 8/5/2011 Consumer United States
Primary
Secondary
Concomitant
Pruritus Male 220 lb 8/6/2011 Consumer United States
Primary
Concomitant
Diarrhoea Disability 10/1/2010 83 Male 9/27/2011 Consumer United States
Primary
Concomitant
Haemorrhoidal Haemorrhage 1/1/2011 68 Female 10/3/2011 Consumer United States
Primary
Concomitant
Renal Disorder 6/4/2010 62 Female 175 lb 10/9/2011 Consumer United States
Primary
Concomitant
Dizziness Other Serious 10/1/2010 83 Male 11/3/2011 Consumer United States
Primary
Concomitant
Pleural Effusion Hospitalization 8/26/2011 56 Female 11/11/2011 Consumer United States
Primary
Concomitant
Syncope Other Serious Female 11/18/2011 Consumer United States
Primary
Secondary
Concomitant
Abnormal Faeces 3/1/2011 62 Female 11/22/2011 Consumer United States
Primary
Concomitant
Cognitive Disorder Other Serious 11/15/2011 63 Male 185 lb 12/5/2011 Pharmacist United States
Primary
Concomitant
Chronic Obstructive Pulmonary Disease Hospitalization 8/26/2011 56 Female 1/3/2012 Consumer United States
Primary
Concomitant
Burning Sensation Other Serious Female 1/3/2012 Consumer United States
Primary
Concomitant
Drug Ineffective Hospitalization 8/26/2011 56 Female 1/24/2012 Consumer United States
Primary
Concomitant
Asthenia Other Serious 10/31/2011 79 Male 1/25/2012 Consumer United States
Primary
Secondary
Concomitant
Blood Creatinine Increased Other Serious 3/8/2000 57 Male 1/6/2012 Physician United States
Primary
Concomitant
Bronchitis Hospitalization 86 Female 3/23/2012 Consumer United States
Primary
Concomitant
Dyspnoea 4/2/2012 Female 4/23/2012 Consumer United States
Primary
Concomitant
Weight Decreased Hospitalization 86 Female 5/9/2012 Consumer United States
Primary
Concomitant
Drug Dose Omission Other Serious Female 132 lb 5/10/2012 Consumer United States
Primary
Concomitant
Dyspnoea 4/2/2012 Female 5/16/2012 Consumer United States
Primary
Concomitant
Therapeutic Response Decreased Hospitalization 82 Female 5/16/2012 Consumer United States
Primary
Secondary
Concomitant
Fatigue Female 170 lb 5/29/2012 Consumer United States
Primary
Concomitant
Palpitations Hospitalization 1/1/2012 52 Female 5/29/2012 Other Health Professional Australia
Primary
Concomitant
Infarction Other Serious 55 Female 6/29/2012 Other Health Professional Finland
Primary
Secondary
Concomitant
Acute Coronary Syndrome Death 7/2/2012 Physician Finland
Primary
Secondary
Concomitant
Pain Other Serious 77 Female 5/9/2011 Consumer United States
Primary
Concomitant
Influenza Like Illness Hospitalization 9/17/2010 80 Female 5/9/2011 Consumer United States
Primary
Concomitant
Vascular Resistance Pulmonary Increased Other Serious Female 7/19/2012 Physician United States
Primary
Concomitant
Pain In Extremity Other Serious 55 Female 7/20/2012 Other Health Professional Finland
Primary
Secondary
Concomitant
Drug Ineffective Other Serious 8/3/2012 Consumer Finland
Primary
Secondary
Concomitant
Osteoporosis Hospitalization 82 Female 8/8/2012 Consumer United States
Primary
Secondary
Concomitant
Malignant Neoplasm Progression Death Male 10/19/2012 Other Health Professional Us
Primary
Concomitant
Oropharyngeal Pain Disability 12/3/2012 72 Male 247 lb 12/19/2012 Physician Gb
Primary
Concomitant
Arthralgia 12/2011 61 Male 1/28/2013 Consumer Country Not Specified
Primary
Concomitant

Drug Data